Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
OncoSec Medical (DE:ONMA)
FRANKFURT:ONMA
Holding DE:ONMA?
Track your performance easily
ONMA Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€0.11 - €0.14
Previous Close€0.14
Volume0.00
Average Volume (3M)N/A
Market Cap
€6.00
Enterprise Value-€1.98M
Total Cash (Recent Filing)$3.68M
Total Debt (Recent Filing)$1.55M
Price to Earnings (P/E)―
Beta-1.83
Next Earnings
Mar 12, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding5,960,000
10 Day Avg. Volume2,763
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)-0.15
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda0.06
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
OncoSec Medical News
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
―
Mutual Funds
2.12% Other Institutional Investors
97.88% Public Companies and
Individual Investors
ONMA FAQ
What was OncoSec Medical’s price range in the past 12 months?
OncoSec Medical lowest stock price was €0.11 and its highest was €0.14 in the past 12 months.
What is OncoSec Medical’s market cap?
Currently, no data Available
When is OncoSec Medical’s upcoming earnings report date?
OncoSec Medical’s upcoming earnings report date is Mar 12, 2025 which is in 132 days.
How were OncoSec Medical’s earnings last quarter?
Currently, no data Available
Is OncoSec Medical overvalued?
According to Wall Street analysts OncoSec Medical’s price is currently Overvalued.
Does OncoSec Medical pay dividends?
OncoSec Medical does not currently pay dividends.
What is OncoSec Medical’s EPS estimate?
OncoSec Medical’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does OncoSec Medical have?
OncoSec Medical has 5,962,652 shares outstanding.
What happened to OncoSec Medical’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of OncoSec Medical?
Currently, no hedge funds are holding shares in DE:ONMA
---
Company Description
OncoSec Medical
OncoSec Medical, Inc. is a biotechnology company, which engages in designing, developing, and commercializing therapies for the treatment of cancer. Its lead product candidate, ImmunoPulse IL-12, uses an electroporation device, with the aim of reversing the immunosuppressive microenvironment in the treated tumor. The company was founded by Avtar S. Dhillon and Punit S. Dhillon on February 8, 2008 and is headquartered inPennington, NJ.
---
Technical Analysis
Inovio Pharmaceuticals
―
Oncternal Therapeutics
―
Cellectar Biosciences
―
Immutep
―
OncoSec Medical
―
---